期刊文献+

抗氧化治疗对糖尿病肾脏病患者肾功能的保护作用 被引量:1

Protective effect of antioxidative therapy with vitamin E and vitamin C on renal function in diabetic nephropathy patients
下载PDF
导出
摘要 目的探讨维生素E联合维生素C抗氧化治疗对2型糖尿病肾脏病患者肾功能的保护作用。方法选择我院2型糖尿病肾脏病患者80例,随机分为2组,对照组(A组)接受常规治疗;抗氧化治疗组(B组)除常规治疗外,口服维生素E(0.1g/次,每日1次)、维生素C(0.2g/次,每日3次)。每3个月随访1次,观察记录患者的肾功能,以血肌酐(SCr)升高1倍为随访终点,SCr升高1倍所经历的时间为肾功能生存时间,最长随访时间为2年。结果A组肾功能平均生存时间为(14.78±0.64)个月;B组平均生存时间为(18.16±0.68)个月,2组比较有统计学差异(P〈0.05)。结论维生素E联合维生素c抗氧化治疗对糖尿病肾脏病患者肾功能具有保护作用。 Objective To investigate the protective effect of antioxidative therapy with vitamin E and vitamin C on renal function in patients with diabetic nephropathy (DN). Methods An prospective randomized controlled trial was performed to investigate the protective effect of antioxidative ther-apy in patients with type 2 diabetic nephropathy. A total of 80 DN patients were recruited in Air Force General Hospital. These patients were randomly divided into two groups: control group (goup A) and trial group (group B). Each group had 40 patients respectively. The patients in group A received usual treatment, and those in group B received antioxidative agents besides usual treatment. The antioxidative agents were vitamin E (0. 1 g/time, per os, 1 time/day) and vitamin C (0. 2 g/time, per os, 3 times/day). At scheduled visits of every three months all patients underwent examination of serum ereatinine (SCr). The follow-up endpoint was the day when Ser was increased by one fold. The survival time of renal function was defined as the time from the start to the endpoint of follow-up. The longest follow-up period was 2 years. Results The mean survival time of renal function in group B was longer than that in group A (18. 16±0. 68) vs (14. 78±0. 64) months, log-rank P〈0. 05). Condusions The antioxidative therapy in combination with vitamin E and vitamin C has protective effect on renal function in diabetic nephropathy patients.
出处 《临床肾脏病杂志》 2011年第10期467-469,共3页 Journal Of Clinical Nephrology
关键词 抗氧化剂 氧化性应激 糖尿病肾脏病 Antioxidante Oxidative stress Diabetic nephropathies
  • 相关文献

参考文献12

  • 1BrownleeM. The pathobiology of diabetic complications: A unifying mechanism. Diabetes, 2005,54:1615-1625.
  • 2Gabir M, Hanson RL, Debelea D, et al. PIasma glucose and prediction of microvascular disease and mortality:Evaluation of 1997American Diabetes Association and 1999 World Health Organization criteria for diagnosis of diabetes. Diabetes Care, 2000, 23: 1113-1118.
  • 3Yamagishi S, Matsui T. Advanced glycation end products, oxidative stress and diabetic nephropathy. Oxid Med Cell Longer, 2010,3:101-108.
  • 4Susztak K, Raff AC, SehifferM, et al. Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depetion at the onset of diabetic nephropathy. Diabetes,2006,55: 225- 233.
  • 5Lee EA, Seo JY, J iang Z, et al. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney. Kidney Int, 2005, 67:1762-1771.
  • 6Wu J, Mei C, Vlassara H, et al. Oxidative stress-induced JNK activation contributes to proinflammatory phenotype of aging diabetic mesangial cells. Am J Physiol Renal Physiol, 2009, 297: F1622-F1631.
  • 7Vaziri ND, Bai Y, Ni Z, et al. Intra-renal angiotensin II/ATI receptor,oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther, 2007,323 : 85-93.
  • 8Jaimes EA, Hua P, Tian RX, et al. Human glomerular endothelium: Interplay among glucose, free fatty aclds, angiotensin II, and oxidative stress. Am J Physiol Renal Physiol, 2010, 298: F125- F132.
  • 9Li C, Cai F, Yang Y, et al. Tetrahydroxystilbene glucoside ameliorates diabetic nephropathy in rats: Involvement of SIRT1 and TGF-i31 pathway. Eur J Pharmacol,2010,649:382-389.
  • 10Winiarska K, Szymanski K, Gorniak P, et al. Hypoglycaemic, antioxidative and nephroprotective effects of taurine in alloxan diabetic rabbits. Biochimie, 2009,91: 261-271.

同被引文献6

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部